progenics.comProgenics Pharmaceuticals | Developing Innovative Cancer Therapies
progenics.com Profile
progenics.com is a domain
that was created on 1997-11-09,making it 27 years ago.
It has several subdomains, such as ir.progenics.com , among others.
Description：Progenics is focused on developing innovative drugs to improve the lives of prostate cancer patients and their families. Learn more about our therapeutic...
Discover progenics.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
progenics.com Information
| HomePage size: 21.884 KB |
| Page Load Time: 0.525002 Seconds |
| Website IP Address: 96.125.169.163 |
progenics.com Similar Website
| Cancer Epigenetics | A journal of the Cancer Epigenetics Society | Cancer Epigenetics |
| BTF Cancer Center - Transforming Cancer Treatment in Nepal |
| Pediatric Cancer Research Foundation | PCRF | Childhood Cancer Charity |
| Insight – Cancer Information You Can Trust | Dana-Farber Cancer Institute |
| Home - 2023 Targeted Therapies of Lung Cancer Meeting |
| Community Cancer Services | Mount Sinai Cancer Collaborative |
| Cancer Statistics Center - American Cancer Society |
| Optical Cancer Imaging Lab - Screening and Diagnosis with LightOptical Cancer Imaging Lab | Screenin |
| MD Anderson Cancer Center: Cancer Treatment & Cancer Research Hospital | MD Anderson Cancer Center |
| Investor Relations | Progenics Pharmaceuticals, Inc. |
| Lifeline Pharmaceuticals, LLC’s Login Page | Lifeline Pharmaceuticals, LLC |
| Neuropathix, Inc. – A Phyto-Medical Company | Developing Pharmaceuticals to Protect the Brain |
progenics.com PopUrls
| Lantheus - Diagnostic and Therapeutic Innovations http://www.progenics.com/product-pipeline/azedra/ |
| Lantheus - Diagnostic and Therapeutic Innovations https://www.progenics.com/ |
progenics.com DNS
| A progenics.com. 3600 IN A 96.125.169.163 |
| MX progenics.com. 3600 IN MX 10 us-smtp-inbound-1.mimecast.com. |
| NS progenics.com. 3600 IN NS ns1.hvdata.net. |
| TXT progenics.com. 3600 IN TXT knowbe4-site-verification=6ccea2ae1f1c66818caf3e9f81da5624 |
| SOA progenics.com. 3600 IN SOA mrbodnsmaster101.nss.crowncastle.com. hostadmin.crowncastle.com. 2020072520 10800 3600 2419200 300 |
progenics.com Httpheader
| Date: Mon, 10 Aug 2020 00:02:24 GMT |
| Server: Apache |
| Link: https://www.progenics.com/wp-json/; rel="https://api.w.org/", https://www.progenics.com/; rel=shortlink |
| X-UA-Compatible: IE=edge,chrome=1 |
| Connection: close |
| Transfer-Encoding: chunked |
| Content-Type: text/html; charset=UTF-8 |
progenics.com Meta Info
| charset="utf-8"/ |
| content="width=1050px; maximum-scale=1.0;" name="viewport" |
| content="Progenics is focused on developing innovative drugs to improve the lives of prostate cancer patients and their families. Learn more about our therapeutic technologies." name="description"/ |
| content="en_US" property="og:locale"/ |
| content="website" property="og:type"/ |
| content="Progenics Pharmaceuticals | Developing Innovative Cancer Therapies" property="og:title"/ |
| content="Progenics is focused on developing innovative drugs to improve the lives of prostate cancer patients and their families. Learn more about our therapeutic technologies." property="og:description"/ |
| content="https://www.progenics.com/" property="og:url"/ |
| content="Progenics" property="og:site_name"/ |
| content="summary" name="twitter:card"/ |
| content="Progenics is focused on developing innovative drugs to improve the lives of prostate cancer patients and their families. Learn more about our therapeutic technologies." name="twitter:description"/ |
| content="Progenics Pharmaceuticals | Developing Innovative Cancer Therapies" name="twitter:title"/ |
progenics.com Ip Information
| Ip Country: United States |
| Latitude: 37.751 |
| Longitude: -97.822 |
progenics.com Html To Plain Text
Progenics Pharmaceuticals, Inc. is now a subsidiary of Lantheus Holdings, Inc. 646-975-2500 Contact Us Pipeline Approved Products AZEDRA – Ultra-Orphan Radiotherapeutic In Development PyL – PSMA Targeted PET Imaging Agent 1095 – Small Molecule Therapeutic Clinical Trials Overview Investors Business Development Overview Become A PartnerVision Management Team Board of Directors Compliance Program Careers Contact Us About Progenics Progenics is an oncology company focused on the development and commercialization of innovative targeted medicines and artificial intelligence to find, fight and follow cancer, including: therapeutic agents designed to treat cancer (AZEDRA ® , 1095, and PSMA TTC); prostate-specific membrane antigen (PSMA) targeted imaging agents for prostate cancer (PyL™ and 1404); and imaging analysis technology (aBSI and PSMA AI). Progenics has three commercial products, AZEDRA, for the treatment of patients with unresectable, locally advanced or metastatic pheochromocytoma or paraganglioma (rare neuroendocrine tumors of neural crest origin) who require systemic anticancer therapy; and oral and subcutaneous formulations of RELISTOR ® (methylnaltrexone bromide) for the treatment of opioid-induced constipation, which are partnered with Bausch Health Companies Inc. Progenics is proud to have joined the Lantheus family. Lantheus, a global leader in the field of medical imaging, develops, manufactures and commercializes essential diagnostic imaging agents and products that help healthcare professionals identify disease and improve patient treatment and care. Learn more Product Pipeline Our pipeline includes drug candidates in all stages of development. See All Contact Us Privacy Policy Legal Notice Compliance Trademarks, registered or otherwise, are the property of their respective owner. © 2020 Lantheus Holdings, Inc. All rights reserved. Intended for U.S. Residents only. 331 Treble Cove Road, N. Billerica, MA 01862 Telephone: 1-800-362-2668 Use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy...
progenics.com Whois
Domain Name: PROGENICS.COM Registry Domain ID: 616797_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2020-09-08T15:15:50Z Creation Date: 1997-11-09T05:00:00Z Registry Expiry Date: 2024-11-08T05:00:00Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: domain.operations@web.com Registrar Abuse Contact Phone: +1.8777228662 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.HVDATA.NET Name Server: NS2.HVDATA.NET DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T20:30:34Z <<<